CAS: 1093108-50-9; 2-(4,6-Bis(Dimethylamino)-2-(4-(4-(Trifluoromethyl)Benzamido)Benzyl)Pyrimidin-5-yl)Acetic Acid

结构式图片

上下游产品

4-Nitrophenylacetonitrile [4,6-dichloro-2-(4-nitrobenzyl)pyrimidin-5-yl]acetic acid methyl ester [4,6-dihydroxy-2-(4-nitrobenzyl)pyrimidin-5-yl]acetic acid methyl ester [4,6-bis-dimethylamino-2-(4-nitrobenzyl)pyrimidin-5-yl]acetic acid methyl ester [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl]acetic acid choline salt N-methyl-D-glucamine [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl] acetate

合成工艺路线路线简述

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Hall IP, Fowler AV, Gupta A, Tetzlaff K, Nivens MC, Sarno M, Finnigan HA, Bateman ED, Rand Sutherland E. Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. Pulm Pharmacol Ther. 2015 Jun;32:37-44. doi: 10.1016/j.pupt.2015.03.003. Epub 2015 Apr 8. doi: 10.1016/j.jaci.2013.10.013. Epub 2013 Dec 9.

    合成参考文献


    摘要:S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知